Category - Pharma Industry News
Gilead and Novo Nordisk’s NASH trial meets primary endpoint
UK strikes deal for five million doses of Moderna’s COVID-19 vaccine
NHS launches 40 ‘long COVID’ clinics
£12.2m boost for coronavirus genomic surveillance
J&J launches second PhIII COVID-19 trial
Six new medicines leap towards EU approval
Synairgen’s SNG001 advances into phase 3 COVID-19 trial
Sobi’s Gamifant receives final rejection from CHMP for primary HLH